Behavioral Exercise Training to Reduce Cardiovascular Disease Risk
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexMale
Age40-85
SponsorVirginia Commonwealth University
About this trial
To test the preliminary effectiveness of a home-based exercise training (ET) intervention to improve exercise capacity (VO2 peak \& 6-minute walk distance \[6MWD\]) among prostate cancer (PC) patients compared to controls receiving healthy living education (HLE) at 12 weeks.
Eligibility criteria
Qualifiers
Be diagnosed with stage II/III/IV prostate cancer
Be currently undergoing treatment with ADT (intermittent or prolonged)
Have completed local curative-intent treatment, including prostatectomy or definitive radiation;
Be >40 years of age up to 85;
Disqualifiers
Be unable to undergo MRI (i.e., ferromagnetic materials in body, inability to lie flat, claustrophobia);
Have contraindications to exercise testing;
Have pre-existing overt cardiovascular disease/heart failure;
Active illness/infection;
Trial design
Treatments tested in this trial
- Exercise Training Intervention
- Healthy Living Education
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Virginia Commonwealth University
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov